RALEIGH, NC and LUGANO, SWITZERLAND -- (Marketwired) -- 04/22/13 -- DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, and the Swiss pharmaceutical Helsinn ...

DARA BioSciences, Inc (NASDAQ:DARA) a development stage biopharmaceutical company that engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates is currently up ...

New York, NY - (NISMAGAZINE) - 04/25/2013- Noranda Aluminum Holding Corporation (NYSE:NOR) moved 6.99% lower, at $4.14, was amongst the day losers, after opening at $4.22.

New York, NY - (NISMAGAZINE) - 4/28/2013- DARA Biosciences Inc (NASDAQ:DARA) gained 1.84% at $0.780 after trading 304,741 shares.

New York, NY - (NISMAGAZINE) - 04/24/2013- Noranda Aluminum Holding Corporation (NYSE:NOR) moved 28.18% higher, at $4.23, was among the day gainers, after opening at $3.32.

RALEIGH, NC--(Marketwired - May 15, 2013) - DARA BioSciences, Inc. ( NASDAQ : DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today its financial results for the first quarter ended ...

Mr. D'Alonzo's extensive pharmaceutical industry background also includes a number of executive positions, including Chief Executive Officer at biotechnology companies DARA BioSciences, Inc. and GenVec, Inc. and President and Chief Operating Officer at ...